Fighting Antimicrobial Resistance:
from the
Biological EmergencY to Opportunistic and Neglected Diseases
Dimicare Biotech is a spin-off from University Côte d'Azur (UniCA) focused on the development of a new generation of drugs against difficult-to-treat infections. Despite we are interested on different targets, our main project (DCB001) focuses on the development of a new precision treatment against MDR (multidrug-resistant) S. aureus strains (including the WHO priority MRSA; methicillin-resistance S. aureus).
DimiCare is building a great team involving academic researchers, infectiology and microbiology medical doctors, and strategic development experts, assuring a solid growth not only in the scientific but also in the business field.
Juan A. Garcia-Sanchez, PhD
Expert field: host-pathogen interaction - Antimicrobial Resistance (AMR)
Role in the futur start-up: CEO/CSO
Current role: Head of DimiCare Biotech at VIRINFLAM Team from C3M - INSERM U1065 - UniCA
Pauline Meola, MSc
Expert field: host-pathogen interaction - in vitro and in vivo infection models
Role in the futur start-up: CTO microbiology
Current role: Engineer in DimiCare Biotech project at VIRINFLAM Team from C3M - INSERM U1065 - UniCA
Laurent Boyer, PhD
Expert field: host-pathogen interaction - Microbial virulence and host response
Role in the futur start-up: Co-founder "concours scientifique" - Microbiology - Inflammation expert
Current role: Team leader (DRCN, HDR) at VIRINFLAM Team from C3M - INSERM U1065 - UniCA
Cyril Ronco, PhD
Expert field: medicinal chemistry - bioactive molecules against Human diseases
Role in the futur start-up: Co-founder "concours scientifique" - Medicinal Chemistry expert
Current role: Team leader (MCUHC, HDR) at ICN - CNRS UMR7272 - UniCA
Grégory Michel, PhD
Expert field: host-parasite interaction - in vitro and in vivo infection models
Role in the futur start-up: Associate and "concours scientifique" - Host-parasite interaction expert
Current role: Research Engineer (IR) at VIRINFLAM Team from C3M - INSERM U1065 - UniCA
Patrick Munro, PhD
Expert field: host-bacteria interaction - in vitro and in vivo infection models
Role in the futur start-up: Associate and "concours scientifique" - Host-bacteria interaction expert
Current role: Researcher (CRHC) at VIRINFLAM Team from C3M - INSERM U1065 - UniCA
Christelle Pomares-Estran, MD, PhD
Expert field: host-parasite interaction - Clinical parasitology and mycology
Role in the futur start-up: Co-founder "concours scientifique" - Parasitology and Mycology expert
Current role: Head of Department of Parasitology and Mycology (PU-PH, HDR) at CHU of Nice - UniCA
Raymond Ruimy, MD, PhD
Expert field: host-bacteria interaction - Clinical bacteriology
Role in the futur start-up: Clinical advisor - Bacteriology
Current role: Head of Department of Bacteriology (PU-PH, HDR) at CHU of Nice - UniCA
Johan Courjon , MD, PhD
Expert field: host-pathogen interaction - Clinical infectiology
Role in the futur start-up: Clinical advisor - Infectiology
Current role: Reference Doctor for infectious diseases associated to locomotor system at CHU of Nice - UniCA
O. D., PhD
Expert field: Financial strategy - Biotech/Pharmaceutical companies
Role in the futur start-up: Co-founder - Business development expert
Current role: Business developper
We have been the pleasure to share on February the 15th the DimiCare's achievements, goals and challenges for this year. This event allowed us to interact with the local ecosystem, create new connections and consolide ancient ones.
DimiCare has been awarded with the "Best Entrepreneurial Project" Award by the Entrepreneurial Union of the Department of "Alpes-Maritimes" - UPE06.
On November 16th-17th people from all laboratories on France have concentred in Lyon to present their work about our Gold bacteria : Staphylococcus aureus. Of course, our project has been there to interact with other scientist and discuss about our main program DCB001.
It has been a very interesting symposium in this amazing city.
DimiCare Biotech was the subject of the section of Inserm Magazine "Entrepreneurship". It is a real honor to see how our project is beginning to be recognized at a national level.
DimiCare Biotech was the subject of Tribune Côte d'Azur. Thank you for present our work to Côte d'Azur's citoyens !
Our CEO talks about our experience with the SATT-SE, Incubateur and other innovation players in the Côte d'Azur ecosystem.
On October 12th, SATT Sud-Est organized “My Innovation Is” (MI2) an amazing event where many Deeptech projects were presented. MI2 was hosted at the Théâtre du Château de Valrose, and DimiCare Biotech was presented by our CEO in front of an excellent audience: members of the region's innovation ecosystem, colleagues and potential investors...
Our Project leader has been invited to attend the 2nd Annual Nucleate Summit (23rd-25th August) in San Diego (USA), one of the biggest fast-growing international associations boosting biotech entrepreneurship in students and young researchers.
During this meeting, DimiCare has been introduced to many other projects in the healthtech environment and allowed to contact future partners and investors.
Thank you Nucleate to bringing us this opportunity and let's see what the future holds for this wonderful organization which has just started in France (particularly in Nice!).
Last July, our project was announced as awarded of the Call for Projects "Young Innovative Doctors" from "Région Sud Provence-Alpes-Côte d'Azur". This Call for Projects is co-financed with the "SATT-Sud Est" which will participate on the "pre-maturation" of our project. This founding confirm a new year of work and advances in this amazing Deeptech project.
Our project is now starting in an acceleration phase where the proof-of-concept of our technology is getting closer and closer, as well as the creation of our start-up.
The i-PhD, i-Lab and i-Nov Awards/Contest from the National Investment Public Bank "BpiFrance" hold the 4th Edition of National Innovation Prices in July 2023. These prices look for promote early-stage Deeptech startup projects (i-PhD) as well as young (i-Lab) and more advanced innovative companies (i-Nov).
During the Awards Ceremony which took place in Paris on July 4th, our entrepreneurial project was Awarded with the i-PhD Award. It includes a year of "business development training" for our future CEO, which will help us to mature our project and launch the startup in the following months.
The Academic Excellence Award or Prix d'Excellence Académique is an initiative from Fondation UCA which has as its main objective to promote innovation and early-stage startup/spin-off projects coming from the University Côte d'Azur.
Our project has been awarded in the 2023 Edition and our future CEO Juan Garcia-Sanchez had the opportunity to pitch in front of many University Representatives and other entrepreneurs.
Thank "Fondation Université Côte d'Azur" for this Award which values our work and ICE - Innovation Center for Entrepreneurship which proposed our project.
Once obtaining YEP funding from SignaLife - Labex, the project decided to hire MSc. Pauline Meola, our future CTO in DimiCare.
Over the past few years, Pauline Meola has developed her skills in microbiology in the bacteriology department of the University Hospital of Nice (Determination of the virulence of clinical strains of multi-resistant Staphylococcus aureus) as well as in animal experimentation within the Mediterranean Center for Molecular Medicine. (C3M - U1065) in Nice (Development of new therapies against B-lymphoma).
This mixed experience in microbiology and animal models made Pauline the perfect candidate to join DimiCare Biotech, we hope, for a long time.
The SignaLife - Labex Innovation Program has launched a YEP Call for Projects from 2020 with the following objectives: To support innovation within the scientific community of the SIGNALIFE Labex for projects developping new technological and scientific assets linked to research on cell signaling in biology, carried out by or in collaboration with SIGNALIFE Labex teams (IDEX partners), and whose planned development includes the creation of a startup.
DimiCare Biotech has been selected and awarded with this YEP founding which will allow us to work in the end of the early-discovery stage and to develop our proof-of-concept in the following months.
Are you interested on our project?
Here are the different ways to contact us!
Legal Notice © Copyright. All rights reserved.
Nous avons besoin de votre consentement pour charger les traductions
Nous utilisons un service tiers pour traduire le contenu du site web qui peut collecter des données sur votre activité. Veuillez consulter les détails dans la politique de confidentialité et accepter le service pour voir les traductions.